article thumbnail

Pharma IT and AI – 2024 Health IT Predictions

Healthcare IT Today

As we kick off 2024, we wanted to start the new year with a series of 2024 Health IT predictions. Health Economics Outcomes Research (HEOR) will become more common in decentralized clinical trials (DCTs). In fact, we got so many that we had to narrow them down to just the best and most interesting. Dave Latshaw, CEO at BioPhy 1.

article thumbnail

Patients and Industry: Starting Our New Life Together in 2023

Society for Participatory Medicine

This activity sent pharma and biotech companies scrambling to hire DE&I officers and related patient advocacy, engagement, and experience personnel as they came to terms with this foreign notion of actually collaborating with real, live patients. She is currently contracted by Parexel as their first Patient Ambassador.

BioTech 144
article thumbnail

Will Technology Cure Americans’ Health Care System Ills? Considering Google and Ascension Health’s Data Deal

Health Populi

What’s underneath that macro “healthcare” index number of 67 is a precipitous decline in the past year for Americans’ trust in hospitals, compared with biotech, pharma, consumer healthcare, and even health insurance — all of which grew in trust between 2018 and 2019, but not so with the hospital segment of U.S.

BioTech 160